Unknown

Dataset Information

0

Targeting CXCR4, VLA-4, and CXCR2 for hematopoietic stem cell mobilization.

ABSTRACT:

SUBMITTER: Cancilla D 

PROVIDER: S-EPMC10945136 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.
| S-EPMC3514440 | biostudies-literature
Unknown Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization.
| S-EPMC8115334 | biostudies-literature
Unknown Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.
| S-EPMC10500469 | biostudies-literature
Unknown Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide
| S-EPMC10214082 | biostudies-literature
Unknown Plasminogen regulates stromal cell-derived factor-1/CXCR4-mediated hematopoietic stem cell mobilization by activation of matrix metalloproteinase-9.
| S-EPMC3159162 | biostudies-literature
Unknown Targeting VLA4 integrin and CXCR2 mobilizes serially repopulating hematopoietic stem cells.
| S-EPMC6597242 | biostudies-literature
Unknown Osteolineage niche cells initiate hematopoietic stem cell mobilization.
| S-EPMC2481533 | biostudies-literature
Unknown Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells.
| S-EPMC5445573 | biostudies-literature
Unknown Hematopoietic stem cell mobilization with plerixafor in sickle cell disease.
| S-EPMC5927977 | biostudies-literature
Unknown Rapid Mobilization Reveals a Highly Engraftable Hematopoietic Stem Cell.
| S-EPMC5812290 | biostudies-literature